<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02492412</url>
  </required_header>
  <id_info>
    <org_study_id>Huons</org_study_id>
    <nct_id>NCT02492412</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of HE10 for Dry Eye Syndrome</brief_title>
  <official_title>Multi-center, Randomized, Double-blind, Active Comparator- Controlled, Parallel Study Evaluating the Efficacy and Safety of HE10 in Subjects With Dry Eye Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huons Co.,Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huons Co.,Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of HE10 eye drop for the
      patients with moderate to severe dry eye syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is to compare the efficacy and safety of HE10 and Restasis for patients with
      moderate to severe dry eye syndrome in multi-center, double-blind, randomized, active
      comparator-controlled, parallel design, non-inferiority Phase III clinical trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal staining Test to assess eye dryness</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change from baseline in eye dryness at 12 weeks</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">101</enrollment>
  <condition>Dry Eye Syndrome</condition>
  <arm_group>
    <arm_group_label>HE10</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug: HE10 1~2 drops b.i.d at 12 hour interval for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Restasis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug: Restasis(Cyclosporine 0.05%) 1~2 drops b.i.d at 12 hour interval for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HE 10</intervention_name>
    <arm_group_label>HE10</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Restasis</intervention_name>
    <arm_group_label>Restasis</arm_group_label>
    <other_name>0.05% cyclosporine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Corneal staining score of â‰¥2(Oxford grade)

          -  Schirmer test score (without anesthesia) &lt; 10 mm/5 min in either eye

          -  Tear break-up time is 10 seconds or less

          -  Screening both eyes, the corrected visual acuity is 0.2 or more

        Exclusion Criteria:

          -  Current or recent patients used dry eye syndrome medications (topical or systemic)
             that may affect the status

          -  The patients with systemic or ocular disorders affected the test result

          -  Being treated with systemic steroid

          -  History of eyeball surgical operation within 3 months of screening visit

          -  Wearing contact lenses within 2 weeks of screening visit

          -  Be a use or used punctual plug within 1 month of screening vist

          -  Use of cyclosporine eye drop within 3 weeks

          -  Pregnancy or Breastfeeding

          -  Intraocular pressure &gt; 25 mmHg

          -  Abnormal eyelid function : Disorders of the eyelids or eyelashes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2015</study_first_submitted>
  <study_first_submitted_qc>July 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2015</study_first_posted>
  <last_update_submitted>July 5, 2015</last_update_submitted>
  <last_update_submitted_qc>July 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cyclosporins</mesh_term>
    <mesh_term>Cyclosporine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

